BM
Last reporting period 30 Jun, 2024
Updated —
Last price
—
Market cap $B
100.34
Exchange
XSWX - Six Swiss Exchange
4.135
Last period Financial Leverage ,USD
54%
Financial Leverage has increased in 5 years
What is Financial Leverage ?
Financial leverage is a multiplier that shows how much of a company's assets are financed by debts and other liabilities assumed. The higher the value of this indicator, the more often the company resorts to borrowing to purchase new assets.
See also Bristol-Myers
Company Analysis
BMY.SW valuation, rating, competitors, insights and company profile
Eyestock Rating
BMY.SW financial analysis by Eyestock methodology
Valuation
BMY.SW valuation using historical relative method
Statements
BMY.SW Income Statements, Balance Sheet and Cash Flow Statements
Dividends
BMY.SW dividend yield and annual dividend
Financial leverage is a multiplier that shows how much of a company's assets are financed by debts and other liabilities assumed. The higher the value of this indicator, the more often the company resorts to borrowing to purchase new assets.
Bristol-Myers`s Financial Leverage for the last twelve months ended 2024-06-30 is 4.135
